Stability of floxuridine and leucovorin calcium admixtures for intraperitoneal administration
The stability of floxuridine and leucovorin calcium in admixtures of 0.9% sodium chloride injection at various concentrations, temperature conditions, and time points was determined. Admixtures of floxuridine and leucovorin calcium were prepared in 1-L plastic bags containing 0.9% sodium chloride in...
Saved in:
Published in | American journal of hospital pharmacy Vol. 46; no. 5; p. 985 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.1989
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The stability of floxuridine and leucovorin calcium in admixtures of 0.9% sodium chloride injection at various concentrations, temperature conditions, and time points was determined. Admixtures of floxuridine and leucovorin calcium were prepared in 1-L plastic bags containing 0.9% sodium chloride injection. Admixtures containing the following three concentrations were prepared: floxuridine 1 g and leucovorin calcium 30 mg, floxuridine 2 g and leucovorin calcium 240 mg, and floxuridine 4 g and leucovorin calcium 960 mg. The admixtures were stored at refrigerated temperature (4-8 degrees C), ambient room temperature (20 degrees C), and near-physiologic body temperature (40 degrees C). Drug concentrations were measured with a stability-indicating high-performance liquid chromatographic (HPLC) method at 0, 4, 8, 24, and 48 hours (4-8 degrees C) and at 0, 1, 3, 6, 24, and 48 hours (20 degrees C and 40 degrees C). A second set of samples at the same concentrations was prepared and sequentially stored at refrigerated, room, and near-physiologic temperatures to simulate actual-use conditions; these samples were assayed by HPLC at 0, 4, 8, 24, and 48 hours (4-8 degrees C); 49, 51, 54, and 60 hours (20 degrees C); and 61, 63, 66, and 72 hours (40 degrees C). All solutions were protected from light. Floxuridine and leucovorin calcium were stable at each concentration and temperature condition tested for a minimum of 48 hours. However, leucovorin calcium was more subject to decomposition at near-physiologic temperature than at other temperatures, with the most degradation at the lowest concentration. |
---|---|
AbstractList | The stability of floxuridine and leucovorin calcium in admixtures of 0.9% sodium chloride injection at various concentrations, temperature conditions, and time points was determined. Admixtures of floxuridine and leucovorin calcium were prepared in 1-L plastic bags containing 0.9% sodium chloride injection. Admixtures containing the following three concentrations were prepared: floxuridine 1 g and leucovorin calcium 30 mg, floxuridine 2 g and leucovorin calcium 240 mg, and floxuridine 4 g and leucovorin calcium 960 mg. The admixtures were stored at refrigerated temperature (4-8 degrees C), ambient room temperature (20 degrees C), and near-physiologic body temperature (40 degrees C). Drug concentrations were measured with a stability-indicating high-performance liquid chromatographic (HPLC) method at 0, 4, 8, 24, and 48 hours (4-8 degrees C) and at 0, 1, 3, 6, 24, and 48 hours (20 degrees C and 40 degrees C). A second set of samples at the same concentrations was prepared and sequentially stored at refrigerated, room, and near-physiologic temperatures to simulate actual-use conditions; these samples were assayed by HPLC at 0, 4, 8, 24, and 48 hours (4-8 degrees C); 49, 51, 54, and 60 hours (20 degrees C); and 61, 63, 66, and 72 hours (40 degrees C). All solutions were protected from light. Floxuridine and leucovorin calcium were stable at each concentration and temperature condition tested for a minimum of 48 hours. However, leucovorin calcium was more subject to decomposition at near-physiologic temperature than at other temperatures, with the most degradation at the lowest concentration. |
Author | Smith, J A Morris, A Markman, M Duafala, M E Kleinberg, M Bertino, J R |
Author_xml | – sequence: 1 givenname: J A surname: Smith fullname: Smith, J A organization: Division of Pharmacy Services, Memorial Sloan-Kettering Cancer Center, New York, NY 10021 – sequence: 2 givenname: A surname: Morris fullname: Morris, A – sequence: 3 givenname: M E surname: Duafala fullname: Duafala, M E – sequence: 4 givenname: J R surname: Bertino fullname: Bertino, J R – sequence: 5 givenname: M surname: Markman fullname: Markman, M – sequence: 6 givenname: M surname: Kleinberg fullname: Kleinberg, M |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/2524968$$D View this record in MEDLINE/PubMed |
BookMark | eNotj0tLAzEYRbOo1La6dCnkD0ybx0wmWUrxBQUX6lLKl0mCKZlkyGSk_fcW7erCPXA5d4lmMUWL0B0la0oU38Dhe9jUYt2slWxmaEEIYZViUl2j5TgeCOFEynaO5qxhtRJygb7eC2gffDnh5LAL6Thlb3y0GKLBwU5d-knZR9xB6PzUYzC9P5Yp2xG7lLGPJcNgsy9nEwh_OPrxXBaf4g26chBGe3vJFfp8evzYvlS7t-fX7cOu6lhbl8o2LTNaGqGs0m3DuCPOcilAKeqIAi4oaEV4q20DYIWhglLFrWTEEd0qtkL3_7vDpHtr9kP2PeTT_nKT_QJ0w1b_ |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1093/ajhp/46.5.985 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 2524968 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | .GJ 41~ 53G 5RE AAPGJ AAWDT AAWTL ABCQX ABGNP ABJNI ACFRR ACUTJ ACVCV ACZBC ADMTO AFFNX AFFQV AFYAG AGKRT AGMDO AJDVS ALMA_UNASSIGNED_HOLDINGS APJGH AQDSO AVNTJ CGR CUY CVF ECM EIF EIHJH F5P J5H L7B MBLQV NPM OBFPC TMA TN5 WH7 ZGI ZXP |
ID | FETCH-LOGICAL-c274t-e572db8d69e9b7523f0fe386a991f09a361ab9037be5aae6d161193e820f0b792 |
ISSN | 0002-9289 |
IngestDate | Tue Aug 05 11:35:45 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c274t-e572db8d69e9b7523f0fe386a991f09a361ab9037be5aae6d161193e820f0b792 |
PMID | 2524968 |
ParticipantIDs | pubmed_primary_2524968 |
PublicationCentury | 1900 |
PublicationDate | 1989-05-01 |
PublicationDateYYYYMMDD | 1989-05-01 |
PublicationDate_xml | – month: 05 year: 1989 text: 1989-05-01 day: 01 |
PublicationDecade | 1980 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | American journal of hospital pharmacy |
PublicationTitleAlternate | Am J Hosp Pharm |
PublicationYear | 1989 |
SSID | ssj0030887 |
Score | 1.3668588 |
Snippet | The stability of floxuridine and leucovorin calcium in admixtures of 0.9% sodium chloride injection at various concentrations, temperature conditions, and time... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 985 |
SubjectTerms | Chromatography, High Pressure Liquid Drug Combinations Drug Stability Drug Storage Floxuridine - administration & dosage Floxuridine - analysis Injections, Intraperitoneal Leucovorin - administration & dosage Leucovorin - analysis Temperature |
Title | Stability of floxuridine and leucovorin calcium admixtures for intraperitoneal administration |
URI | https://www.ncbi.nlm.nih.gov/pubmed/2524968 |
Volume | 46 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swELYK0yReEBtD48cmPyBeICW1Eyd5ZAiEkDrxUCReELJjW2QqbVVaVPbX7y52k7RsE_ASRXGVuPk-OXfnu-8I2WcWzLYkV0EkuAkiFspAGR4GFr6uhvFc5hoLnLs_xcV1dHkT37Razayl6US1899_rSt5D6pwDXDFKtk3IFvdFC7AOeALR0AYjq_CGCzFMre13CW3_eFsOi40mo0YDe-baT58wvy6Q8AhLzALWT8UM9wyKEUYUCoCa6_GBQpyo2bAgpBu02yt9nUaQhP3vuPI4cipX1ex-SpYc1kHSrvD8dg3Pq5NZ2llv7Rdu3U9xA_M8x647SCfzKhllXQ1zwBsrLMZc82B5uusDzUWzZ3sctHMXNOeF4u5E7qSv-5H2KBJtOP20i8BjdFDiS2LwY10_Xn-O7ikre1HVsgKOBnYNRVDPe4zznH5nftO-Fe8QCtM6hindDyf0Br56G-z5JmUFkpvg6x714KeOJ58Ii0z-EwOrjw6R7RXl9o9HtEDelWrlj9vktuKTHRoaYNMFMhEazJRTyZak4kCmegSmegimb6Q6_Oz3ulF4HtvBDlLoklg4oRplWqRmUwlMeM2tIanQoI_YcNMctGRKgt5okwspREaPAfwBQwYlDZUSca2yOoAnveVUBNFCe_YjgijPFKWpamMUylSJblOdGq3yZZ7bXcjJ7By59_nzr8Gdslazbo98gHY-mi-gXE4Ud9LEP8AILlpJw |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stability+of+floxuridine+and+leucovorin+calcium+admixtures+for+intraperitoneal+administration&rft.jtitle=American+journal+of+hospital+pharmacy&rft.au=Smith%2C+J+A&rft.au=Morris%2C+A&rft.au=Duafala%2C+M+E&rft.au=Bertino%2C+J+R&rft.date=1989-05-01&rft.issn=0002-9289&rft.volume=46&rft.issue=5&rft.spage=985&rft_id=info:doi/10.1093%2Fajhp%2F46.5.985&rft_id=info%3Apmid%2F2524968&rft_id=info%3Apmid%2F2524968&rft.externalDocID=2524968 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9289&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9289&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9289&client=summon |